Neuromuscular complications after hematopoietic stem cell transplantation

scientific article published on 29 March 2014

Neuromuscular complications after hematopoietic stem cell transplantation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00520-014-2225-0
P698PubMed publication ID24682581

P2093author name stringMichael Koldehoff
Susanne Koeppen
Abhiyrahmi Thirugnanasambanthan
P2860cites workGraft-versus-host disease: why have we not made more progress?Q27012940
Increased incidence of neurological complications in patients receiving an allogenic bone marrow transplantation from alternative donors.Q33179317
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group reportQ34474243
Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation.Q34963618
Polymyositis as a manifestation of chronic graft-versus-host diseaseQ35037606
Polymyositis complicating donor lymphocyte infusion after stem cell transplantation for relapsed chronic myeloid leukemia: report of a case and review of literatureQ36579562
Polymyositis after donor lymphocyte infusion.Q40277132
Polymyositis and myocarditis after donor lymphocyte infusionQ40388761
Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literatureQ41474842
Peripheral neuropathy after bone marrow transplantationQ41635311
Graft-versus-host disease-related polymyositisQ43195998
Prospective evaluation of neurological complications after allogeneic bone marrow transplantationQ43994969
Myasthenia gravis after allogeneic bone marrow transplantation treated with mycophenolate mofetil monitored by peripheral blood OX40+ CD4+ T cells.Q44235080
Life-threatening neurological complications after bone marrow transplantation in childrenQ45143160
Acute polymyositis after donor lymphocyte infusionQ45227575
Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease.Q48401354
Neurological complications of hematopoietic stem cell transplantation (HSCT): a retrospective study in a HSCT center in BrazilQ48867436
Acute neuropathies after peripheral blood stem cell and bone marrow transplantationQ60976781
Myasthenia gravis after allogeneic bone marrow transplantation for lymphoblastic lymphomaQ73338182
Chronic demyelinating polyneuropathy in graft-versus-host disease following allogeneic bone marrow transplantationQ74176571
Early neurologic complications following allogeneic bone marrow transplant for leukemia: a prospective studyQ74575128
Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-host-diseaseQ74664210
Correlation of peripheral blood OX40+(CD134+) T cells with chronic graft-versus-host disease in patients who underwent allogeneic hematopoietic stem cell transplantationQ77136492
Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapyQ79836234
Occurrence of autoantibodies in chronic graft vs. host disease after allogeneic stem cell transplantationQ80945824
Dermatomyositis-like muscle pathology in patients with chronic graft-versus-host diseaseQ84384688
P433issue9
P304page(s)2337-2341
P577publication date2014-03-29
P1433published inSupportive Care in CancerQ15766919
P1476titleNeuromuscular complications after hematopoietic stem cell transplantation
P478volume22

Reverse relations

cites work (P2860)
Q92619758Chronic Graft-Versus-Host-Disease-Related Polymyositis: a 17-Months-Old Child with a Rare and Late Complication of Haematopoietic Stem Cell Transplantation
Q52974741High prevalence of small- and large-fiber neuropathy in a prospective cohort of patients with moderate to severe chronic GvHD.
Q90326304Neurologic complications after allogeneic transplantation: a meta-analysis
Q33913077Progressive hypoventilation due to mixed CD8+ and CD4+ lymphocytic polymyositis following tremelimumab - durvalumab treatment
Q53737471[Paraplegia after hematopoietic stem cell transplantation].